子宫内膜腺癌孤立性脾转移的18F-FDG PET/CT表现
本文报告一例47岁女性子宫内膜腺癌患者,1年前行全腹子宫切除术、双侧输卵管卵巢切除术及盆腔淋巴结清扫术。再分期18F-FDG PET/CT显示脾脏孤立性肿块伴FDG摄取增高,无其他复发征象。病灶经手术切除后诊断为子宫内膜腺癌脾转移。
要点
- 子宫内膜腺癌脾转移罕见,尤其当脾为唯一转移部位时。
- 18F-FDG PET/CT可显示脾脏孤立性高代谢病灶,提示转移可能。
- 手术切除病灶后病理确诊为子宫内膜腺癌转移。
核心结论
- 子宫内膜腺癌患者再分期时,18F-FDG PET/CT发现脾脏孤立性高代谢肿块,手术切除后病理证实为脾转移。
研究设计与样本
- 病例报告:一例47岁女性子宫内膜腺癌患者,既往行全腹子宫切除术、双侧输卵管卵巢切除术及盆腔淋巴结清扫术,再分期行18F-FDG PET/CT检查。
主要发现
- 再分期18F-FDG PET/CT显示脾脏孤立性肿块伴FDG摄取增高,无其他复发征象。
- 病灶经手术切除后诊断为子宫内膜腺癌转移。
临床怎么用
- 对于子宫内膜腺癌患者再分期时,18F-FDG PET/CT发现脾脏孤立性高代谢病灶应警惕转移可能,可考虑手术切除以明确诊断。
局限性
- 本文为单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Splenic metastasis from endometrial carcinoma is rare, especially when the spleen is the sole metastatic site. Herein, we report the case of a 47-year-old woman with a history of endometrial adenocarcinoma diagnosed 1 year ago. At that time, she underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, and pelvic node dissection. Restaging F-FDG PET/CT demonstrated an isolated splenic mass with elevated FDG activity. There were no other signs of recurrence. The lesion was surgically resected and diagnosed as a metastasis from the endometrial adenocarcinoma.
引用
- Xu T, Cen B, Liu L, et al. 18F-FDG PET/CT Findings of an Isolated Splenic Metastasis From Endometrial Adenocarcinoma. Clin Nucl Med. 2020. PMID: 32956116. doi:10.1097/RLU.0000000000003280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。